Septic arthritis due to Mycobacterium kansasii is rare; only 40 cases have been published. A French national inquiry revealed the occurrence of 10 new cases between 1992 and 1997 (8 men and 2 women: mean age, 37 years; range, 25-54 years). Seven had an underlying condition: AIDS ( ), chronic skin psoriasis and AIDS ( ), or a renal transplant ( n = 4 n = 2 n = ). Trauma to the joint, use of intra-articular corticosteroid(s) 1 month to 2 years after the 1 event, and chronic skin psoriasis were risk factors. The mean interval between appearance of the first symptoms of arthritis and the diagnosis was 5 months. Monarthritis was localized to the knee ( ), wrist ( ), finger ( ), elbow ( ), or ankle ( ). The main n = 4 n = 3 n = 1 n = 1 n = 1 diagnostic procedure was culture of a synovial biopsy specimen. In all cases, debridement was associated with antimycobacterial treatment. Three patients died of AIDS during treatment, and another is still undergoing treatment; the other 6 patients were cured. M. kansasii infection should be considered in all cases of indolent arthritis with any of the following risk factors: local trauma, local or systemic corticosteroid therapy, chronic skin psoriasis, and immunodepression, especially that due to human immunodeficiency virus infection.
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Although Mycobacterium kansasii is one of the major pulmonary mycobacterial pathogens, it is rarely identified as a cause of extrapulmonary infections, especially septic arthritis, which is extremely rare. In France, Mycobacterium avium and Mycobacterium xenopi are more frequently associated with infection, and in Australia Mycobacterium kansasii is rare [1, 2] . We describe 10 new cases of M. kansasii septic arthritis that occurred between 1993 and 1998 and review the 40 previously published cases.
Patients and Methods
We retrospectively reviewed the laboratory records of all patients whose synovial biopsies and/or joint fluid cultures yielded M. kan- sasii isolates in testing at the French National Center of Mycobacteria at the Institut Pasteur (Paris) between 1 July 1993 and 15 July 1998. Mycobacteria had been identified by means of conventional tests. Six patients' strains were subjected to additional molecular tests, including PCR with K1 and K2 primers, and restrictionenzyme analysis of the heat-shock-protein-65 gene, as described elsewhere [2] .
Then the hospital records of all adult patients (aged 115 years) were obtained and reviewed. For each patient, we recorded age, sex, date of first symptoms, clinical findings, clinical diagnoses, associated medical conditions, selected laboratory results, treatment, and outcome. Drug susceptibilities on Lö wenstein-Jensen (L-J) medium were determined with use of the proportion method, as is usual for testing tubercle bacilli. MICs on Middlebrook 7H11 medium were determined for other drugs, including amikacin, quinolones (sparfloxacin and ciprofloxacin), rifabutin, and clarithromycin.
Previous reports on septic arthritis due to M. kansasii were found by a MEDLINE search of the literature from the period of 1 January 1963 to 31 December 1998. The references cited in these articles were then used to locate other publications. Joint fluid Direct examination kansasii septic arthritis, which involved 8 men and 2 women (mean age, 37 years; range, 25-54 years). All patients presented with the same clinical picture: the affected joint was swollen and chronically painful, but there was no fever, although 1 patient had night sweats. The mean interval between appearance of the first symptoms of arthritis and the diagnosis was 5 months (range, 1-12 months). The localization (of monarthritis, in all cases) was as follows: knee ( ), wrist ( ), n = 4 n = 3 finger ( ), elbow ( ), or ankle ( ). n = 1 n = 1 n = 1 Laboratory findings. The main diagnostic procedure was culture of synovial biopsy specimens (table 1), which was positive for every specimen tested. Histologic examinations of these samples were not as informative as cultures; only 70% of these were positive. Direct examination of joint fluid was the least contributive, yielding only 1 positive result. Culture of the fluid was as informative, percentage-wise, as histologic staining, despite taking more time, but the same specimens were not necessarily positive with the 2 tests.
Results

Patients
As reported elsewhere [3] , all strains were susceptible to rifampin, ethambutol, and thiacetazone but resistant to streptomycin and pyrazinamide. MICs were high for amikacin (∼16 mg/mL, and even higher for half of the strains), varied for ciprofloxacin (2 mg/mL) and sparfloxacin (0.25 mg/mL, except for 1 strain with an MIC of 1 mg/mL), and were very low for clarithromycin (0.12 or 0.25 mg/mL) and rifabutin (all !0.1 mg/ mL). Low-range rifampin MICs (0.25-5 mg/mL) were noted, in agreement with findings obtained on L-J medium. For this drug, it should be noted that L-J medium strongly inhibits the antibiotic, thereby explaining the distinct MIC ranges associated with its use.
Risk factors and associated conditions. Of the 10 patients, 7 had an underlying condition: HIV infection only ( ), n = 4 chronic skin psoriasis and HIV infection ( ), or a renal n = 2 transplant ( ). The 4 HIV-negative patients had experienced n = 1 trauma to the joint and received 1 or several intra-articular corticosteroid injections, 1 month to 2 years after the event. One HIV-negative patient had chronic skin psoriasis. The 6 HIV-infected patients already had AIDS, along with CD4 ϩ lymphocyte counts !100/mm 3 . Among them, only 1 had experienced trauma and 1 had received intra-articular steroids. The interval between trauma and diagnosis was 2 months for the HIV-infected patients and ranged from 4 months to 16 years for HIV-negative patients.
Management and outcome. Various combinations of 3 drugs ( ) or 2 drugs ( ) were used in all cases, along n = 8 n = 2 with surgical debridement. Therapy lasted at least 18 months. Three patients with AIDS died during treatment, and 1 is still receiving treatment. The 6 other patients were cured after completion of the regimen (mean duration, 12 months; range, 9-18 months).
Literature Review and Discussion
M. kansasii musculoskeletal infections are rare. M. kansasii was first described in 1953 by Buhler and Pollack [4] . This human pathogen has also been isolated from a patient hospitalized for a pulmonary infection in Kansas City [5] . The first term used was "yellow bacillus," because M. kansasii produces a yellow pigment on exposure to light. Since that time, this microorganism has been recognized primarily as a pulmonary pathogen, but rare cases of localized extrapulmonary (genitourinary tract, skin) or disseminated infection have been reported [6, 7] . Most published reports indicated that tendonsheath infections and septic arthritis are the usual manifestations of M. kansasii musculoskeletal infections [8] .
A recent history of steroid therapy and/or local trauma have frequently been associated with M. kansasii septic arthritis and/ or tenosynovitis in adults with no systemic disease. Many patients had received local injection of corticosteroids prior to the onset of the typical signs of infection. This risk factor has been reported by several authors [9, 10] . Although the precise mechanism of this association is unknown, steroids might allow a previously dormant M. kansasii colonization to become established [11] .
Mycobacterial diseases are a major cause of morbidity and death among HIV-infected patients, and tuberculosis can occur at any stage of AIDS. Infection due to M. avium complex, the most common nontuberculous pathogen in AIDS patients, is well recognized as a late-stage manifestation. M. kansasii is the second most common nontuberculous mycobacterium isolated from patients with AIDS and is usually responsible for pulmonary infection, which generally responds well to antituberculosis therapy [7, 12, 13] .
Disseminated mycobacterial disease has been reported to occur in HIV-negative, immunologically compromised hosts with the following conditions: rheumatoid arthritis [8] , systemic lupus erythematosus [8, 14, 15] , myelodysplasia [16] , polymyositis [14] , and a renal transplant [8] . In contrast to patients without systemic disease, these immunocompromised patients usually had systemic symptoms, such as fever, malaise, anorexia, weight loss, and/or cough. Previously altered joints (affected by lupus, rheumatoid arthritis, or psoriatic arthritis) may favor a local infection and its hematogenous spread. In our study, the average interval before accurate diagnosis was 14 months after an indolent and progressive course.
M. kansasii is the most common nontuberculous mycobacterial cause of monoarticular synovitis. Usually, systemic illness and an elevated erythrocyte sedimentation rate are absent. Synovitis is often moderate, and symptoms are often mild and consist of stiffness or tingling of the involved joint. Arthrocentesis yields inflammatory but not purulent synovial fluid. Acidfast staining for mycobacterial bacilli is often negative, and the organism is isolated in !15% of cases. A synovial biopsy is often necessary to confirm the diagnosis. When a biopsy is performed, tissue specimens should be cultured on media adapted for mycobacteria.
The 40 cases of articular and/or periarticular M. kansasii infections that have been reported since 1963 can be divided into 2 groups. The first includes 23 previously healthy adults [9, 10, 14, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] , and to these cases we added 3 new ones, for a total of 26 patients: 17 men and 9 women, with an average age of 48 years (range, 13-82 years; table 2). The second group includes 17 patients with an underlying systemic disease [8, [14] [15] [16] [27] [28] [29] [30] [31] [32] [33] [34] [35] , and to these cases we added the 7 new ones described above, for a total of 24. These patients had HIV infection ( ), systemic lupus erythematosus ( ), rheun = 13 n = 2 matoid arthritis ( ), renal transplant ( ), polymyositis n = 3 n = 3 ( ), progressive systemic sclerosis ( ), or myelodysplasia n = 1 n = 1 ( ). The average age of the 14 men and 7 women was 45 n = 1 years (range, 20-79 years); the sex and age are unknown for 3 patients (table 3). All HIV-positive patients had progressed to AIDS and had CD4 ϩ lymphocyte counts !100/mm 3 . For the first group (no systemic disease), the monoarticular localization of septic arthritis was distributed as follows: wrist (38%), knee (19%), finger (19%), or elbow (8%). Polyarthritis was found in 8% of the cases. A history of recent in situ steroid therapy (39%) or local trauma (39%) was frequently associated with the diagnosis. Of the patients with systemic disease, 46% had disseminated disease and/or polyarthritis; for the others, the septic arthritis was primarily localized to the wrist (21%), the knee (17%), or the elbow (13%). A recent history of systemic steroid therapy (42%) was frequently noted. Of the patients reported in the literature and our 10, 7 had chronic skin psoriasis.
For all patients, the interval between the onset of symptoms and the diagnosis was long (mean, 14 months; range, 1-60 months). The main diagnostic procedure was culture of a synovial biopsy specimen. Radiographic films of the joints were usually normal, apart from tissue swelling, and there is often no radiographic evidence of pulmonary disease associated with M. kansasii arthritis. Therapy, as generally recommended, was with a combination of surgery, consisting of debridement of infected tissue (synovectomy) and excision of osteitic bone when necessary, and antimycobacterial agents.
In accordance with the Centers for Disease Control and Prevention and the American Thoracic Society [36, 37] , combination chemotherapy included several of the following drugs: isoniazid, rifampin, ethambutol, streptomycin, cycloserine, and erythromycin or clarithromycin, with rifampin and ethambutol being the most commonly prescribed. Some studies showed a good outcome without isoniazid [3] . Our M. kansasii strains were susceptible in vitro to sparfloxacin, ciprofloxacin, clarithromycin, or sulfamethoxazole, in agreement with previous reports, which also noted susceptibility to ofloxacin [38] [39] [40] . Therapy lasted for at least 18 months.
Although the organism is relatively resistant in vitro to lowdose isoniazid and is resistant to pyrazinamide, rifampin usually has good clinical activity against M. kansasii. However, acquired resistance to rifampin has rarely been reported [41] . Because the response to appropriate antibiotic combinations is good, prolonged pain and stiffness could be avoided if the diagnosis were made early and treatment initiated rapidly.
M. kansasii infections, like all mycobacterial infections other than tuberculosis, are considered to be environmentally acquired. Most mycobacteria are common in the environment and may be encountered in surface waters, including oceans, estuaries, lakes, rivers, ponds, and tap water, but also in soil, dust, and different plant species. In contrast, M. kansasii has a relatively narrow ecological niche, primarily restricted to tap water, but it also grows in sphagnum moss. The species is very well adapted to this manmade environment and has been reported to survive for up to 12 months in tap water, whereas it did not survive in soil [42] .
A recent study, based on the use of several independent molecular markers and conducted on clinical strains and water isolates, showed that the species could be separated into 5 subspecies. None of these subspecies appears to be more virulent, since all groups contained clinical and environmental strains [2] . These observations point to the possible role of water as the vehicle of transmission of M. kansasii to humans. Among the patients included in this study, iatrogenic infection (corticosteroid therapy) could be suspected in ∼42% of the cases, with the water solutions used for injected drugs or an unknown mechanism potentially responsible. [reference]
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